Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Christopher L Cooper

2PUBLICATIONS

10CO-AUTHORS

Major global burdens of diseaseAnimal protection (incl. pests and pathogens)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jan 08, 2025

Seroprevalence of Antibodies to Filoviruses with Outbreak Potential in Sub-Saharan Africa: A Systematic Review to Inform Vaccine Development and Deployment.

Christopher S Semancik, Hilary S Whitworth, Matt A Price

|Oct 27, 2022

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials.

Christopher L Cooper, Gavin Morrow, Maoli Yuan

Pageof 1

Frequent Collaborators

1 joint publications

Gavin Morrow

1 joint publications

John W Coleman

1 joint publications

Kristie Valentin

1 joint publications

Thomas W Geisbert

1 joint publications

Christopher S Semancik

1 joint publications

Hilary S Whitworth

1 joint publications

Heejin Yun

1 joint publications

Thomas S Postler

1 joint publications

Marija Zaric

1 joint publications

Andrew Kilianski

Frequent Collaborators

1 joint publications

Gavin Morrow

1 joint publications

John W Coleman

1 joint publications

Kristie Valentin

1 joint publications

Thomas W Geisbert

Top Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on : Sep 27, 2014

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos

Top Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on : Sep 27, 2014

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos